Related Experiment Video
Updated: Jan 4, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Dendritic Cells Drive Osteosarcomagenesis through Newly Identified Oncogene and Tumor Suppressor
1Departments of Orthopaedics and Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah. Kevin.jones@hci.utah.edu.
Abstract:
GRM4, a GWAS-suspected tumor suppressor, is tested in a mouse model of osteosarcomagenesis as well as the putative oncogene it suppresses, IL23. Both are expressed in and exert the bulk of their influence among tumor-infiltrating myeloid-derived antigen-presenting cells, rather than osteosarcoma cells.See related article by Kansara et al., p. 1511.
Insights
The study investigated GRM4 and IL23 in osteosarcoma, finding they influence tumor-infiltrating myeloid cells, not cancer cells. This suggests a new therapeutic target for osteosarcoma treatment.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- The gene GRM4 is suspected to be a tumor suppressor based on Genome-Wide Association Studies (GWAS).
- Interleukin-23 (IL23) is a cytokine implicated in various cancers and is investigated as a potential oncogene.
- Osteosarcoma is a primary bone cancer with complex genetic and cellular interactions.
Purpose of the Study:
- To investigate the roles of GRM4 and IL23 in a mouse model of osteosarcomagenesis.
- To determine the cellular context in which GRM4 and IL23 exert their functions within the tumor microenvironment.
- To explore the potential of targeting these genes or their associated pathways in osteosarcoma.
Main Methods:
- Utilized a mouse model to study osteosarcomagenesis.
- Analyzed the expression patterns of GRM4 and IL23 within the tumor microenvironment.
- Investigated the cellular localization and functional impact of GRM4 and IL23 on different cell types within the tumor.
Main Results:
- Both GRM4 and IL23 were found to be expressed in tumor-infiltrating myeloid-derived antigen-presenting cells.
- The primary influence of GRM4 and IL23 was observed within these myeloid cells, rather than directly within osteosarcoma cells.
- This indicates a significant role for the tumor microenvironment, specifically myeloid-derived cells, in osteosarcoma development and progression.
Conclusions:
- GRM4 and IL23 play crucial roles in the tumor microenvironment, particularly within myeloid-derived antigen-presenting cells.
- Their influence on osteosarcomagenesis occurs through these immune cells, suggesting a non-cell-autonomous mechanism.
- Targeting GRM4 or IL23 within the tumor-infiltrating myeloid compartment may represent a novel therapeutic strategy for osteosarcoma.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

